TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/29/2026
Back to search
Official data from USPTO
VERONA PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
06/30/2026
Trademark type
Combined
Nice classes
5, 42, 44
Filing date
02/27/2025
Registration date
10/28/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/28/2025
Last transaction
06/30/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
3
Owner type
99
Owner location
LONDON, GB
Examiner
MORRIS, ALINA S.
Law office
M80
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the wording "VERONA PHARMA" in stylized font, with a design of a circle with straight lines in varying lengths emanating out from it, and with three of the straight lines in the upper right of the design detached from the circle.
Holders and representatives
Holders
VERONA PHARMA LIMITED
Verona Pharma PLC
Representatives
Palak Mayani Merck & Co., Inc.
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations and substances for the treatment of cardiovascularcentral nervous systempulmonaryrespiratoryautoimmune diseases and disorders for human use; Pharmaceutical preparations and substances for the treatment of respiratory conditions and diseasechronic obstructive pulmonary diseasecystic fibrosis and asthma
Class 42
Scientific research for medical purposes in the field of the treatment of cardiovascularcentral nervous systempulmonaryrespiratoryautoimmune diseases and disorders; Scientific research for medical purposesthe research and development of pharmaceutical preparations for the treatment of respiratory conditions and diseasein particularchronic obstructive pulmonary diseasecystic fibrosis and asthma
Class 44
Medical treatment services for the treatment of cardiovascularcentral nervous systempulmonaryrespiratoryautoimmune diseases and disorders; Provision of medical information and services; Information provided to patients and healthcare professionals concerning pharmaceutical productsvaccinesmedical diseases and disorders and related treatments; Medical treatment services in the field of respiratory conditions and diseasechronic obstructive pulmonary diseasecystic fibrosis and asthma; Provision of medical information and services in the field of respiratory conditions and diseasechronic obstructive pulmonary diseasecystic fibrosis and asthma
Publications
History of USPTO decisions and trademark events.
26 publications found
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
06/29/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/29/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/29/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/29/2026
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/29/2026
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
05/20/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/28/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
10/28/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/09/2025
PUBO
PUBLISHED FOR OPPOSITION
09/09/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/03/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/11/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/07/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/07/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/07/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/02/2025
GNRT
NON-FINAL ACTION E-MAILED
08/02/2025
CNRT
NON-FINAL ACTION WRITTEN
08/02/2025
DOCK
ASSIGNED TO EXAMINER
08/01/2025
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
07/22/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/22/2025
TAEA
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
03/04/2025
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
03/04/2025
MAFR
APPLICATION FILING RECEIPT MAILED
02/27/2025
NWAP
NEW APPLICATION ENTERED
02/27/2025
Continuous trademark protection
Get notified about every new filing that threatens VERONA PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.